UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Operating income declines at top 10 biotechs on KOSDAQ
Top 10 biotech companies on the secondary KOSDAQ market posted significant ...
by Nam Doo-hyun
|
2018-11-22 11:15
라인
Celltrion CEO involved in alleged ‘gapjil’ scandal
Celltrion Chairman Seo Jung-jin has reportedly pulled a power trip – ...
by Lee Han-soo
|
2018-11-21 16:02
라인
US data crucial for Korean biosimilars after success in Europe
Korean biosimilar makers will find it more critical to achieve meaningful r...
by Nam Doo-hyun
|
2018-11-21 15:29
라인
FDA OKs sale of Celltrion's HIV biosimilar
Temixys, a generic developed by Celltrion to treat the human immunodeficien...
by Lee Han-soo
|
2018-11-21 12:57
라인
Intron Bio inks ₩750 billion licensing deal for anti-superbug drug
Intron Biotechnology said it has signed a landmark deal for an investigatio...
by So Jae-hyeon
|
2018-11-20 15:00
라인
Celltrion Healthcare presents research results on using biosimilars in Europe
Celltrion Healthcare said Monday that it has presented the financial saving...
by Lee Han-soo
|
2018-11-19 16:57
라인
Bridge Bio applies for idiopathic pulmonary fibrosis treatment in US
Bridge Biotherapeutic announced on Monday that the company has filed an inv...
by Lee Han-soo
|
2018-11-19 11:58
라인
Tego Science sales plunge in Q3
Tego Science said Thursday that its sales plunged to 2.1 billion won ($1.8 ...
by Lee Han-soo
|
2018-11-16 14:54
라인
NIBEC wins patent for novel peptide in US
Nano Intelligence Biomedical Engineering Corporation (NIBEC) has acquired a...
by Lee Han-soo
|
2018-11-16 14:40
라인
Samsung BioLogics fiasco hardly affects biotech stocks
The suspension of trading of Samsung BioLogics shares did not have a much n...
by Nam Doo-hyun
|
2018-11-16 11:30
라인
Medipost mark profit losses in Q3
Medipost said Thursday that it recorded an operating loss of 780 million wo...
by Lee Han-soo
|
2018-11-15 15:18
라인
[News Focus] Biotechs to suffer shocks from Samsung BioLogics mess
The stock trading suspension of Samsung BioLogics due to the alleged accoun...
by So Jae-hyeon
|
2018-11-15 14:56
라인
Celltrion Healthcare posts ₩212.7 billion in Q3 sales
Celltrion Healthcare, a subsidiary of Celltrion, said Thursday that it reco...
by Lee Han-soo
|
2018-11-15 12:43
라인
Regulators suspend trading of Samsung BioLogics on accounting fraud charges
The Korean Exchange suspended the share trading of Samsung BioLogics on Wed...
by Lee Han-soo
|
2018-11-14 18:28
라인
Alteogen promote antibody-drug conjugate cancer treatment in US
Alteogen said Wednesday that it promoted ALT-P7, an antibody-drug conjugate...
by Lee Han-soo
|
2018-11-14 16:59
라인
GCAM opens new plasma collection centers in US
GCAM, GC’s sister company, said Friday that it has added two additional pla...
by Lee Han-soo
|
2018-11-09 17:58
라인
GC launches Biocon’s antidiabetic biosimilar
GC said Thursday that it has launched Biocon’s Glargia (insulin glargine), ...
by Lee Han-soo
|
2018-11-08 15:46
라인
'Biosimilar makers to benefit from new research accounting guideline'
The Financial Supervisory Service’s recent guidelines for research and deve...
by Nam Doo-hyun
|
2018-11-07 11:23
라인
Biois seeks KOSDAQ listing with ‘technology exception policy’
Biois Corp. said it would utilize the government’s “technology exception po...
by So Jae-hyeon
|
2018-11-06 15:43
라인
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun
|
2018-11-06 15:41
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top